ArticleJournal of endocrinological investigation2026
Metabolic and renal effects of combined SGLT-2 inhibitors and GLP1-R agonists therapy in type 2 diabetes: a real-world analysis across DKD and non-DKD patients.
L Mazzeo et al.PubMed ↗Publisher ↗
No numbers read from the abstract.